Clinical Trials
4 trialsNCT01241591 2018-12-26
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Pfizer
Phase 3 Completed
NCT01313221 2017-03-15
REFINE
Amgen
Phase 3 Completed
NCT00111449 2013-05-15
Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis
Amgen
Phase 3 Completed
NCT00111436 2013-04-26
Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects
Amgen
Phase 3 Completed